Billiontoone (NASDAQ:BLLN) Trading 6.3% Higher – Still a Buy?

Shares of Billiontoone, Inc. (NASDAQ:BLLN) traded up 6.3% during trading on Monday . The company traded as high as $94.16 and last traded at $93.13. 56,477 shares were traded during mid-day trading, a decline of 77% from the average session volume of 249,816 shares. The stock had previously closed at $87.57.

Wall Street Analyst Weigh In

BLLN has been the topic of several recent analyst reports. Stifel Nicolaus initiated coverage on Billiontoone in a research note on Monday, December 1st. They issued a “buy” rating and a $145.00 price target on the stock. Wells Fargo & Company began coverage on Billiontoone in a report on Monday, December 1st. They set an “equal weight” rating and a $110.00 price objective on the stock. Jefferies Financial Group initiated coverage on Billiontoone in a research note on Monday, December 1st. They set a “hold” rating and a $117.00 target price for the company. BTIG Research restated a “buy” rating and issued a $160.00 price target on shares of Billiontoone in a research note on Wednesday, December 10th. Finally, Wall Street Zen raised shares of Billiontoone to a “hold” rating in a report on Saturday, November 15th. Six equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Billiontoone currently has an average rating of “Moderate Buy” and an average target price of $135.29.

Billiontoone Stock Up 0.6%

The company’s fifty day moving average is $97.47. The company has a market capitalization of $3.94 billion and a P/E ratio of 860.50.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings results on Tuesday, December 9th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.06). The firm had revenue of $83.52 million for the quarter, compared to the consensus estimate of $82.86 million.

Institutional Investors Weigh In On Billiontoone

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Billiontoone in the fourth quarter worth approximately $1,348,000. Baillie Gifford & Co. bought a new stake in shares of Billiontoone during the 4th quarter worth $103,786,000. Massachusetts Financial Services Co. MA acquired a new position in shares of Billiontoone in the 4th quarter worth $13,373,000. FNY Investment Advisers LLC acquired a new stake in shares of Billiontoone during the fourth quarter worth $497,000. Finally, Green Alpha Advisors LLC purchased a new stake in shares of Billiontoone during the fourth quarter valued at $436,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.